Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy
- DOI
- 10.1016/j.ymthe.2025.11.021
- Published
- 2026-03
- Container
- Molecular Therapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymthe.2025.11.021,
title = {Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy},
author = {Joshua K.M. Wong and Pui Yeng Lam and Elaina Coleborn and Jiya Jose and Louisa Alim and Cui Tu and Magdalena Antczak and Bettina Dietmair and Arghavan Golbaz Hagh and Lucia Noronha and Seth W. Cheetham and John Hooper and Paul A. Beavis and Delphine Merino and Jean Berthelet and Lauren G. Aoude and Amy E. McCart-Reed and Sunil Lakhani and Peter T. Simpson and Gustavo R. Rossi and Andrew J. Brooks and Martina L. Jones and Fiona Simpson and Fernando Souza-Fonseca-Guimaraes},
year = {2026},
journal = {Molecular Therapy},
doi = {10.1016/j.ymthe.2025.11.021},
url = {https://doi.org/10.1016/j.ymthe.2025.11.021}
}RIS
TY - JOUR TI - Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy AU - Joshua K.M. Wong AU - Pui Yeng Lam AU - Elaina Coleborn AU - Jiya Jose AU - Louisa Alim AU - Cui Tu AU - Magdalena Antczak AU - Bettina Dietmair AU - Arghavan Golbaz Hagh AU - Lucia Noronha AU - Seth W. Cheetham AU - John Hooper AU - Paul A. Beavis AU - Delphine Merino AU - Jean Berthelet AU - Lauren G. Aoude AU - Amy E. McCart-Reed AU - Sunil Lakhani AU - Peter T. Simpson AU - Gustavo R. Rossi AU - Andrew J. Brooks AU - Martina L. Jones AU - Fiona Simpson AU - Fernando Souza-Fonseca-Guimaraes PY - 2026 JO - Molecular Therapy DO - 10.1016/j.ymthe.2025.11.021 UR - https://doi.org/10.1016/j.ymthe.2025.11.021 ER -
APA
Wong, J. K., Lam, P. Y., Coleborn, E., Jose, J., Alim, L., Tu, C., Antczak, M., Dietmair, B., Hagh, A. G., Noronha, L., Cheetham, S. W., Hooper, J., Beavis, P. A., Merino, D., Berthelet, J., Aoude, L. G., McCart-Reed, A. E., Lakhani, S., Simpson, P. T., Rossi, G. R., Brooks, A. J., Jones, M. L., Simpson, F., & Souza-Fonseca-Guimaraes, F. (2026). Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.11.021
Source records
- crossref · retrieved 2026-09-25T23:22:28.884Z